Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)

PHASE3CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

April 30, 2000

Study Completion Date

June 30, 2007

Conditions
Advanced Hodgkin Disease
Interventions
DRUG

COPPEBVCAD vs BEACOPP vs ABVD

Trial Locations (1)

41100

Centro Oncologico Modenese, Modena

All Listed Sponsors
lead

Gruppo Italiano Studio Linfomi

OTHER

NCT00443677 - Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) | Biotech Hunter | Biotech Hunter